Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Price
Target price
€231.10

€231.10

-1.030%
-2.4
-1.030%
-
 
02.09.25 / Frankfurt WKN: A14Y65 / Name: Penumbra / Stock / Healthcare Equipment & Supplies / Mid Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction

Penumbra Inc Stock

A loss of -1.030% shows a downward development for Penumbra Inc.

Pros and Cons of Penumbra Inc in the next few years

Pros
?
M***** P*******
?
W********* I********* f** t** n*** y****
?
G***** c******* t* c**********
Cons
?
B****
?
C******** o* t** e**********
?
S********** s********
Tell us your opinion to access the 'Wisdom of the Crowds'

Performance of Penumbra Inc vs. its peers

Security Change(%) 1w 1m 1y YTD 3y 5y
Penumbra Inc -1.030% 3.136% 12.260% 29.399% 2.773% 40.663% 29.722%
Bio-Rad Labs Inc. A -0.860% -0.078% 3.370% -16.470% -18.943% -47.903% -40.514%
Neogen Corp. -2.850% 0.830% 17.961% -66.712% -59.500% - -
Haemonetics Corp. -0.880% -1.299% -28.750% -31.940% -39.603% -37.959% -38.378%

News

Penumbra (PEN) Q2 Revenue Jumps 13%
Penumbra (PEN) Q2 Revenue Jumps 13%

Penumbra (NYSE:PEN), a medical device innovator focused on clot removal and vascular care, reported its second quarter 2025 results on July 29, 2025. The company delivered $339.5 million in GAAP

3 Mid-Cap Medical Stocks Outperforming the Market
3 Mid-Cap Medical Stocks Outperforming the Market

While major market indexes like the S&P 500 have struggled to gain traction in 2025 and remain in the red YTD, certain pockets of the market are showing impressive strength. Several medical and

Penumbra Stock: Executives Sell Shares Amid Strong Growth
Penumbra Stock: Executives Sell Shares Amid Strong Growth

Several high-ranking executives at Penumbra Inc. have recently sold substantial amounts of company stock, with transactions beginning in early March 2025. Board member Arani Bose divested shares